{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:22:21Z","timestamp":1785370941651,"version":"3.55.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":3524,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1093\/annonc\/mdq191","type":"journal-article","created":{"date-parts":[[2010,6,16]],"date-time":"2010-06-16T23:51:37Z","timestamp":1276732297000},"page":"v220-v222","source":"Crossref","is-referenced-by-count":55,"special_numbering":"S5","title":["Neuroendocrine bronchial and thymic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up"],"prefix":"10.1016","volume":"21","author":[{"given":"K.","family":"\u00d6berg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Hellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Kwekkeboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jelic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdq191_bb0010","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u2018carcinoid\u2019: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq191_bb0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0169-5002(02)00080-6","article-title":"Pulmonary neuroendocrine tumors: incidence and prognosis of histological subtypes: a population-based study in Denmark","volume":"37","author":"Skuladottir","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1093\/annonc\/mdq191_bb0020","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1309\/3PDN-PMT5-EQTM-H0CD","article-title":"Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases","volume":"114","author":"Moran","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1093\/annonc\/mdq191_bb0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.pcr.0000251143.63180.39","article-title":"Neuroendocrine lung tumors","volume":"II","author":"Travis","year":"2006","journal-title":"Path Case Rev"},{"key":"10.1093\/annonc\/mdq191_bb0030","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1309\/AJCP9H1OTMUCSKQW","article-title":"Neuroendocrine carcinomas of the lung: a critical analysis","volume":"131","author":"Moran","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1093\/annonc\/mdq191_bb0035","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/JTO.0b013e31818b06e3","article-title":"The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer","volume":"3","author":"Travis","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1093\/annonc\/mdq191_bb0040","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/00000478-199808000-00003","article-title":"Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid","volume":"22","author":"Travis","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/mdq191_bb0045","first-page":"3425","article-title":"Prognostic markers in patients with typical bronchial carcinoid tumors","volume":"85","author":"Granberg","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/annonc\/mdq191_bb0050","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1148\/radiographics.22.2.g02mr01351","article-title":"Bronchial carcinoid tumors of the thorax: spectrum of radiologic findings","volume":"22","author":"Jeung","year":"2002","journal-title":"Radiographics"},{"key":"10.1093\/annonc\/mdq191_bb0055","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ejcts.2004.05.052","article-title":"Surgical treatment of neuroendocrine tumors of the lung","volume":"26","author":"Daddi","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"issue":"Suppl 2","key":"10.1093\/annonc\/mdq191_bb0060","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1093\/annonc\/12.suppl_2.S111","article-title":"Chemotherapy and biotherapy in the treatment of neuroendocrine tumours","volume":"12","author":"Oberg","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdq191_bb0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.uct.2006.04.007","article-title":"Neuroendocrine tumours","volume":"1","author":"Granberg","year":"2006","journal-title":"Update Cancer Therapeut"},{"key":"10.1093\/annonc\/mdq191_bb0070","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nrendo.2009.105","article-title":"Peptide-receptor radionuclide therapy for endocrine tumors","volume":"5","author":"Van Essen","year":"2009","journal-title":"Nat Rev Endocrinol"},{"key":"10.1093\/annonc\/mdq191_bb0075","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00259-006-0355-4","article-title":"Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin","volume":"34","author":"Van Essen","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419396395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419396395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/21\/suppl_5\/v220\/482438\/mdq191.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T14:13:50Z","timestamp":1635776030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419396395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":14,"alternative-id":["S0923753419396395"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdq191","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}